Invitrogen™ Human LRRFIP1 Synthetic Peptide

Catalog No.	Quantity
PEP1228	50 μg

Catalog No. PEP1228 Supplier Invitrogen™ Supplier No. PEP1228

Description

Synthetic Peptide

LRRFIP1 Synthetic Peptide, PEP-1228, from Invitrogen.

Leucine-rich repeat FLI-I interacting protein 1 (LRRFIP1/FLAP-1) is a MyD88-interacting signal protein which mediates either induction or repression of TLR signaling. Flap-1 directly interacts with β-catenin and activates β-catenin-dependent transcription activity. Flap-1 or LRRFIP1 was also shown to bind the TNF- -308 promoter polymorphism site, suggesting its possible role in the regulation of TNF- production. FLAP-1 along with LRRFIP2 and FLIIH serve as a balance in coordinating inflammatory response after infection, and may act as a novel target in the control of agonist-induced TLR-mediated inflammatory and autoimmune diseases.

Specifications

• Gene ID (Entrez): 9208
• Species: Human
• Purification Method: purified
• Accession Number: Q32MZ4
• Common Name: Human LRRFIP1
• Concentration: 200 μg/mL
• Content And Storage: -20°C
• Description: Synthetic Peptide
• Format: Liquid
• Formulation: PBS with 0.1% BSA and 0.02% sodium azide; pH 7.2
• For Use With (Application): Blocking Assay, Control
• Gene Symbol: LRRFIP1
• Lyophilized: No
• Preservative: 0.02% sodium azide
• Product Type: Peptide
• Quantity: 50 μg
• Regulatory Status: RUO - research use only
• Storage Buffer: PBS